|
Status |
Public on Feb 09, 2015 |
Title |
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome variation profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation missing |
Has this study been published? Please login to update or notify GEO. |
Submission date |
Feb 09, 2015 |
Last update date |
May 15, 2019 |
Contact name |
FRANCESCA STILLITANO |
E-mail(s) |
francesca.stillitano@mssm.edu
|
Phone |
+12128249020
|
Organization name |
Mount Sinai School of Medicine
|
Department |
CARDIOVASCULAR RESEARCH
|
Street address |
1470 Madison Avenue
|
City |
NEW YORK |
State/province |
NY |
ZIP/Postal code |
10029 |
Country |
USA |
|
|
Platforms (1) |
GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
Samples (6)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE65761 |
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy [RNA-Seq] |
GSE65762 |
Correction of human phospholamban R14del mutation associated with cardiomyopathy using targeted nucleases and combination therapy [Exome-Seq] |
|
Relations |
BioProject |
PRJNA274969 |